Receive 50% reimbursement on your initial (if you haven’t had a DEXA scan in the last 6 months) and follow-up DEXA scan when you purchase your Marodyne LiV device. (Reimbursement is capped at £100 per scan).
Please note this offer is only available to customers based in the UK and Ireland.
To receive reimbursement for the 18-month follow-up DEXA scan, the device must be used daily for a minimum of 10 minutes according to the manufacturer’s instructions.
To benefit from the MyBones DEXA Scan reimbursement offer:
Upon completion of the above, MyBones will:
It is at MyBones’ sole discretion whether all eligibility requirements have been met before providing reimbursement. MyBones reserves the right to withdraw, amend or cancel this offer at any time.
You may need to contact your GP before you can book your DEXA scan, as some DEXA providers require GP referrals for private DEXA scans.
If you cannot/choose not to attend your DEXA scan or do not wish to share your results with MyBones, this offer will be deemed to be void, and no additional refund or discount will be provided.
This offer can’t be exchanged, refunded, transferred, or used against the purchase of a Marodyne LiV device.
Your personal information will be used for the purpose of running this promotion and to fulfil the order of your Marodyne LiV device.
See our privacy policy for more information about how MyBones processes personal data.
All results data published in statistics and reports will be anonymised, unless we seek your full permission to publish identifying data such as your name and age alongside your results.
MyBones cannot be held responsible for the privacy or data practices of third-party DEXA scan providers.
MyBones accepts no liability for the practices of or services provided by third-party DEXA scan providers.
MyBones is not responsible for any additional costs incurred outside of the cost of the DEXA i.e., travel, parking etc.
By agreeing to these terms, you give MyBones permission to publish your anonymised results data in statistics and research.